University of Alberta

Company

Related News

University of Alberta Team Identifies New Drug Target for Antibiotic-Resistant E. coli

University of Alberta researchers have identified the protease GlpG as a new drug target for antibiotic-resistant E. coli, which causes hundreds of thousands of UTI deaths annually. Inhibiting GlpG prevented bacterial adhesion and biofilm formation in laboratory studies. The discovery addresses a global health emergency as antimicrobial resistance projections show it could cause cancer-level deaths by 2050.

Related Clinical Trials

NCT ID Title Status Phase
NCT07773025

Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PD

NOT_YET_RECRUITING NA
NCT07768839

Potassium Ferrate Hemostatic Sealant-Assisted Early Radial Hemostasis After Transradial Coronary Angiography and PCI

NOT_YET_RECRUITING NA
NCT07760675

Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.

NOT_YET_RECRUITING NA
NCT07758647

NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems

NOT_YET_RECRUITING NA
NCT07702643

Behavioral Intervention and Guided Stepping Training Early Post-Stroke

NOT_YET_RECRUITING NA
NCT07700563

Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies

COMPLETED
NCT07700303

Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)

NOT_YET_RECRUITING NA
NCT07698067

Feasibility Evaluation of WEAR-IT for Hand Therapy After Stroke

NOT_YET_RECRUITING NA
NCT07685639

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

NOT_YET_RECRUITING NA
NCT07682402

Taurine Supplementation in Adolescents With Post-COVID Condition

NOT_YET_RECRUITING PHASE1/PHASE2